Best Practice & Research Clinical Obstetrics & Gynaecology
Volume 24, Issue 3 , Pages 339-352 , June 2010

Coagulation in pregnancy

  • Patrick Thornton, BMSc, MBBCh, FCARCSI (Clinical Research Fellow)
    • ,
  • Joanne Douglas, MD, FRCPC (Clinical Professor)

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of Anesthesia, BC Women's Hospital, Room 1Q72, 4500 Oak Street, V6H 3N1 Vancouver, BC, Canada. Tel.: +1 604 875 2158; Fax: +1 604 875 2733.

References 

  1. Norris LA. Blood coagulation. Best Pract Res Clin Obstet Gynaecol. 2003;17:369–383
  2. Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol. 2003;16:153–168
  3. Dahlman T, Hellgren M, Blombäck M. Changes in blood coagulation and fibrinolysis in the normal puerperium. Gynecol Obstet Invest. 1985;20:37–44
  4. O'Riordan MN, Higgins JR. Haemostasis in normal and abnormal pregnancy. Best Pract Res Clin Obstet Gynaecol. 2003;17:385–396
  5. Sattar N, Greer IA, Rumley A, et al. A longitudinal study of the relationships between haemostatic, lipid and oestradiol changes during normal pregnancy. Thromb Haemost. 1999;81:71–75
  6. Boehlen F, Hohlfeld P, Extermann P, et al. Platelet count at term pregnancy: a reappraisal of the threshold. Obstet Gynecol. 2000;95:29–33
  7. Dalaker K, Prydz H. The coagulation factor VII in pregnancy. Br J Haematol. 1984;56:233–241
  8. Persson BL, Stenberg P, Holmberg P, et al. Transamidating enzymes in maternal plasma and placenta in human pregnancies complicated by intrauterine growth retardation. J Dev Physiol. 1980;2:37–46
  9. Lee CA, Chi C, Pavord SR, et al. The obstetric and gynaecological management of women with inherited bleeding disorders – review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors' Organization. Haemophilia. 2006;12:301–336
  10. Hellgren M, Blombäck M. Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. Gynecol Obstet Invest. 1981;12:141–154
  11. Chi C, Lee CA, Shiltagh N, et al. Pregnancy in carriers of haemophilia. Haemophilia. 2008;14:56–64
  12. Kjellberg U, Andersson NE, Rosen S, et al. APC resistance and other haemostatic variables during pregnancy and the puerperium. Thromb Haemost. 1999;81:527–531
  13. Kruithof EK, Tran-Thang C, Gudinchet A, et al. Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors. Blood. 1987;69:460–466
  14. Bouma BN, Meijers JC. New insights into factors affecting clot stability: a role for thrombin activatable fibrinolysis inhibitor (TAFI; plasma procarboxy peptidase B, plasma procarboxypeptidase U, procarboxypeptidase R). Semin Hematol. 2004;41:13–19
  15. Donohoe S, Quenby S, Mackie I, et al. Fluctuation in levels of antiphospholipid antibodies and increased coagulation activation markers in normal and heparin treated antiphospholipid syndrome. Lupus. 2002;11:11–20
  16. Francalanci I, Comeglio P, Alessandrello Liotta A, et al. D-dimer plasma levels during normal pregnancy measured by specific ELISA. Int J Clin Lab Res. 1997;27:65–67
  17. Chabloz P, Reber G, Boehlen F, et al. TAFI antigen and D-Dimer levels during normal pregnancy and at delivery. Br J Haematol. 2001;115:150–152
  18. Douglas MJ. The use of neuraxial anesthesia in parturients with thrombocytopenia: what is an adequate platelet count?. In:  Halpern SH,  Douglas MJ editor. Evidence-based obstetric anesthesia. Oxford: BMJ books; 2005;p. 165–177
  19. Practice guidelines for obstetric anesthesia. An updated report by the American Society of Anesthesiologists task force on obstetric anesthesia. Anesthesiology. 2007;106:843–863
  20. Ramanathan J, Sibai BM, Vut T, et al. Correlation between bleeding times and platelet counts in women with pre-eclampsia undergoing cesarean section. Anesthesiology. 1989;71:188–191
  21. McDonagh RJ, Ray JG, Burrows RF, et al. Platelet count may predict abnormal bleeding time among pregnant women with hypertension and pre-eclampsia. Can J Anaesth. 2001;48:563–569
  22. Rodgers RPC, Levin PJ. A critical reappraisal of the bleeding time. Semin Thromb Hemost. 1990;16:1–20
  23. Peterson P, Hayes TE, Arkin CF, et al. The preoperative bleeding time lacks clinical benefit. Arch Surg. 1998;133:134–139
  24. Mallet SV, Cox DJA. Thromboelastography. Br J Anaesth. 1992;69:307–313
  25. Samama CM. Should a normal thromboelastogram allow us to perform a neuraxial block? A strong word of warning. Can J Anaesth. 2003;50:761–763
  26. Davies R, Fernando R, Hallworth SP. Hemostatic function in healthy pregnant and pre-eclamptic women: An assessment using the platelet Function Analyzer (PFA®)and Thromboelastograph (TEG®). Anesth Analg. 2007;104:416–420
  27. McCrae KR. Thrombocytopenia in pregnancy: differential diagnosis, pathogenesis and management. Blood Rev. 2003;17:7–14
  28. Sainio S, Kekomāki R, Riikonen S, et al. Maternal thrombocytopenia at term: a population based study. Acta Obstet Gynecol Scand. 2000;79:744–749
  29. Burrows RF. Platelet disorders in pregnancy. Curr Opin Obstet Gynecol. 2001;13:115–119
  30. Beilin Y, Zahn J, Comerford M. Safe epidural analgesia in thirty parturients with platelet counts between 69,000 and 98,000mm−3. Anesth Analg. 1997;85:385–388
  31. Kelton JG. The serological investigation of patients with autoimmune thrombocytopaenia. Thromb Haemost. 1995;74:222–233
  32. Guidelines for the investigation and management of idiopathic thrombocytopenic purpua in adults, children and in pregnancy. Br J Haematol. 2003;120:574–596
  33. Felbinger TW. Laparoscopic splenectomy in a pregnant patient with immune thrombocytopenic purpura. Int J Obstet Anesth. 2007;16:281–283
  34. Beilin Y, Bodian CA, Haddad EM, et al. Practice patterns of anesthesiologists regarding situations in obstetric anesthesia where clinical management is controversial. Anesth Analg. 1996;83:735–741
  35. Breen TW, McNeil T, Dierenfield L. Obstetric anesthesia practice in Canada. Can J Anaesth. 2000;47:1230–1242
  36. Vigil-De Gracia P, Silva S, Montufar C, et al. Anesthesia in pregnant women with HELLP syndrome. Int J Gynaecol Obstet. 2001;74:23–27
  37. Moen V, Dahlgren N, Irestedt L. Severe neurological complications after central neuraxial blockades in Sweden 1990-1999. Anesthesiology. 2004;101:950–959
  38. Sharma SK, Philip J, Whitten CW, et al. Assessment of changes in coagulation in parturients with preeclampsia using thromboelastography. Anesthesiology. 1999;90:385–390
  39. Orlikowski CEP, Rocke DA, Murray WB, et al. Thromboelastography changes in pre-eclampsia and eclampsia. Br J Anaesth. 1996;77:157–161
  40. Lee J-W. von Willebrand Disease, Hemophilia A and B and other factor deficiencies. Int Anesthesiol Clin. 2004;42:59–76
  41. Ragni MV, Bontempo FA, Hassett AC. von Willebrand disease and bleeding in women. Haemophilia. 1999;5:313–317
  42. Kadir RA, Lee CA, Sabin CA, et al. Pregnancy in women with von Willebrand's disease or factor XI deficiency. Br J Obstet Gynaecol. 1998;105:314–321
  43. Mannucci PM. How I treat patients with von Willebrand disease. Blood. 2001;97:1915–1919
  44. Ray JG. DDAVP use during pregnancy: an analysis of its safety for mother and child. Obstet Gynecol Surv. 1998;53:450–455
  45. Mannucci PM, Canciani MT, Rota L, et al. Response of factor VIII/von Willebrand factor to DDAVP in healthy subjects and patients with Haemophilia A and von Willebrand's Disease. Br J Haematol. 1981;47:283–293
  46. Cata JP, Hanna A, Tetzlaff JE, et al. Spinal anesthesia for a cesarean delivery in a woman with type-2M von Willebrand disease: case report and mini-review. Int J Obstet Anesth. 2009;18:276–279
  47. Varughese J, Cohen AJ. Experience with epidural anaesthesia in pregnant women with von Willebrand disease. Haemophilia. 2007;13:730–733
  48. Dhar P, Abramovitz S, DiMichele D, et al. Management of pregnancy in a patient with severe haemophilia A. Br J Anaesth. 2003;91:432–435
  49. Russell Z, Riconda D, Pollack L, et al. Thrombosis in a pregnant hemophilia A carrier after intrapartum recombinant factor VIII. Obstet Gynecol. 2005;105:875–876
  50. Bolton-Maggs PHB, Perry DJ, Chalmers EA, et al. The rare coagulation disorders-review with guidelines for management from the United Kingdom. Haemophilia Centre Doctors' Organisation. Haemophilia. 2004;10:593–628
  51. Girolami A, Scandellari R, Lombardi AM, et al. Pregnancy and oral contraceptives in Factor V deficiency: a study of 22 patients (five homozygotes and 17 heterozygotes) and review of the literature. Haemophilia. 2005;11:26–30
  52. O'Connell MP, Eogan M, Murphy KM, et al. Solvent-detergent plasma as replacement therapy in a pregnant patient with Factor V deficiency. J Matern Fetal Neonatal Med. 2004;16:69–70
  53. Vellinga S, Steel E, Vangenechten I, et al. Successful pregnancy in a patient with factor V deficiency: case report and review of the literature. Thromb Haemost. 2006;95:896–897
  54. Kulkarni AA, Lee CA, Kadir RA. Pregnancy in women with congenital factor VII deficiency. Haemophilia. 2006;12:413–416
  55. Jiminez-Yuste V, Villar A, Morado M, et al. Continuous infusion of recombinant activated factor VII during caesarean section delivery in a patient with congenital factor VII deficiency. Haemophilia. 2000;6:588–590
  56. Welsh A, McLintock C, Gatt S, et al. Guidelines for the use of recombinant factor VII in massive obstetric haemorrhage. Aust N Z J Obstet Gynaecol. 2008;48:12–16
  57. Chiossi G, Spero JA, Esaka EJ, et al. Plasma exchange in a case of severe factor X deficiency in pregnancy: critical review of the literature. Am J Perinatol. 2008;25:189–192
  58. Singh A, Harnett MJ, Connors JM, et al. Factor XI deficiency and obstetrical anesthesia. Anesth Analg. 2009;108:1882–1885
  59. McMahon MJ, James AH. Combined deficiency of factors II, VII, IX, and X (Borgschulte-Grigsby deficiency) in pregnancy. Obstet Gynecol. 2001;97:808–809
  60. Girolami A, Zocca N, Girolami B, et al. Pregnancies and oral contraceptive therapy in severe (homozygous) FXII deficiency: a study in 12 patients and a review of the literature. J Thromb Thrombolysis. 2004;18:209–212
  61. Chang J, Elam-Evans , Berg CJ, et al. Pregnancy related mortality surveillance-United States, 1991–1999. MMWR Surveill Summ. 2003;52:1–8
  62. Drife J. Thromboembolism. In: Why mothers die. Report on confidential enquiries into maternal deaths in the United Kingdom 2002–2004. London: RCOG Press; 2004;
  63. Martinelli I, Legnani C, Bucciarelli P, et al. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. Thromb Haemost. 2001;86:800–803
  64. Gherman RB, Goodwin TM, Leung T, et al. Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy. Obstet Gynecol. 1999;94:730–734
  65. Duhl AJ, Paidas MJ, Ural SH, et al. Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes. Am J Obstet Gynecol. 2007;197:457;e1–e21
  66. Middeldorp S, Libourel EJ, Hamulyák K, et al. The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden. Br J Haematol. 2001;113:553–555
  67. Pabinger I. Thrombophilia and its impact on pregnancy. Thromb Res. 2009;123:S16–S21
  68. Royal College of Obstetricians and Gynaecologists . Thromboprophylaxis during pregnancy, labour and after normal vaginal delivery. Guideline no. 37. London: RCOG; 2004;Available at www.rcog.org.uk
  69. Samama CM, Albaladejo P, Benhamou D, et al. Venous thromboembolism prevention in surgery and obstetrics: clinical practice guidelines. Eur J Anaesthesiol. 2006;23:95–116
  70. Ginsberg J, Hirsh J, Fifth ACCP. Consensus conference on antithrombotic therapy. Use of antithrombotic agents during pregnancy. Chest. 1998;114:524–531
  71. Bausersachs RM, Dudenhausen J, Faridi A, et al. Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women. Thromb Haemost. 2007;98:1237–1245
  72. Kopp SL, Horlocker TT. Anticoagulation in pregnancy and neuraxial blocks. Anesthesiol Clin. 2008;16:1–22
  73. Gogarten W. The influence of new antithrombotic drugs on regional anesthesia. Curr Opin Anaesthesiol. 2006;19:545–550
  74. Horlocker TT, Wedel DJ, Benzon H, et al. Regional anesthesia in the anticoagulated patient: defining the risks. Reg Anesth Pain Med. 2003;28:172–197

PII: S1521-6934(09)00148-5

doi: 10.1016/j.bpobgyn.2009.11.010

Best Practice & Research Clinical Obstetrics & Gynaecology
Volume 24, Issue 3 , Pages 339-352 , June 2010

Article Tools

* Image Usage & Resolution